ANGX vs TECH · rev $76.5M vs P/E 65, rev $1.22B
Angel Studios, Inc. (ANGX) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Angel Studios, Inc. (ANGX) is a entertainment company listed on NYSE.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported ANGX revenue for 2025-09-30 was $76.5M. Net income was -$38.6M. Revenue was up 280.4% from 2024-09-30 to 2025-09-30. ANGX currently screens at market cap $599.3M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
ANGX currently screens at market cap $599.3M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the ANGX and TECH stock pages for the full models.
Not investment advice.